AdvanSix Inc.
AdvanSix is an integrated chemistry company that produces materials for customers across industries including building and construction, agriculture, plastics, packaging, paints, coatings, electronics and pharmaceuticals. It operates as a single segment through five U.S. manufacturing sites in Pennsylvania, Virginia and Alabama, with headquarters in Parsippany, New Jersey. Its product lines are Nylon Solutions, Plant Nutrients and Chemical Intermediates. AdvanSix sells Nylon 6 resin, primarily under the Aegis® brand, and caprolactam, which is used to make Nylon 6. Its plant nutrients include ammonium sulfate fertilizer, sold primarily under the Sulf-N® brand, as well as ammonia, sulfuric acid and carbon dioxide. Chemical intermediates include acetone, phenol, cyclohexanone, AMS, oximes, cyclohexanol and amines. AdvanSix earns money by manufacturing and selling these products, primarily through direct customer sales, contracts, purchase orders and distributors.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $ASIX in the last 30 days.
See all $ASIX insider activity →AdvanSix (ASIX) reported Q3 sales up 15% YoY to $431M, driven by pricing despite a 2% volume decline. EBITDA fell $10M YoY to $15M due to raw material cost pressures, particularly sulfur and benzene. Free cash flow turned positive at $30M, aided by better working capital management. Management expects continued pricing pressure in Q4, with mixed near-term conditions.
Freedom Capital Markets kept AdvanSix at Buy but reduced its price target to $20 from $22, a 9.1% cut. This implies a 23.2% upside from the Nov 5 close of $16.24.
AdvanSix (ASIX) announced $98M Project CENTURY through 2031, with $47M proposed USDA funding. Q3 2026 saw 15% sales growth YoY, driven by pricing actions, but operational issues reduced production output at key sites, according to CEO Erin Kane.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning ASIX (AdvanSix Inc.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.
Recent ASIX coverage spans earnings, financial news and corporate actions.
Earnings miss and raw‑material cost pressure may weigh on the stock, but pricing strength offers some support.
Freedom Capital Markets kept AdvanSix at Buy but reduced its price target to $20 from $22, a 9.1% cut. This implies a 23.2% upside from the Nov 5 close of $16.24.
The USDA funding proposal supports AdvanSix's growth initiatives, likely boosting investor sentiment.
Earnings miss on EBITDA likely pressures the stock lower.
The grant adds a new growth catalyst for AdvanSix, likely supporting the stock price if USDA approval is secured.
AlphAI scores every news story that mentions ASIX with an AI model for sentiment and relevance, and aggregates insider trades from AdvanSix Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
AdvanSix (ASIX) reported Q3 sales up 15% YoY to $431M, driven by pricing despite a 2% volume decline. EBITDA fell $10M YoY to $15M due to raw material cost pressures, particularly sulfur and benzene. Free cash flow turned positive at $30M, aided by better working capital management. Management expects continued pricing pressure in Q4, with mixed near-term conditions.
Freedom Capital Markets kept AdvanSix at Buy but reduced its price target to $20 from $22, a 9.1% cut. This implies a 23.2% upside from the Nov 5 close of $16.24.
AdvanSix (ASIX) announced $98M Project CENTURY through 2031, with $47M proposed USDA funding. Q3 2026 saw 15% sales growth YoY, driven by pricing actions, but operational issues reduced production output at key sites, according to CEO Erin Kane.
AdvanSix reported Q3 2026 sales up 15% YoY to $431M, but adjusted EBITDA fell $10.1M to $14.6M and adjusted EPS declined $0.32 to -$0.24. Operating cash flow increased $21.4M to $48.0M. The company cited production and input-cost pressures.
AdvanSix (ASIX) was selected for a $47.4M USDA grant to expand ammonia production at its Hopewell, VA facility. The $98.1M project aims to add 84,000 tons of annual capacity, subject to USDA reviews. The grant is part of early-stage capital expenditure not yet reflected in results.
iShares U.S. Infrastructure ETF (IFRA) reported $80.0M gross traded and $79.8M net sold on Tuesday, with $3.5M reduction in Caterpillar (CAT) and smaller buys in ASIX, BXC, MTW, CMP, ASTE. IFRA's assets under management stood at $3.88B.
AdvanSix (NYSE:ASIX) reported Q2 sales of $421 million, up about 3% y/y, but adjusted EBITDA fell $24 million to $32 million and adjusted EPS dropped to $0.19. The company said $72 million higher raw material costs were offset by pricing, while fertilizer demand softened, driving unfavorable volume impacts. Guidance includes ammonia volume growth plans for 2026.
AdvanSix Inc. (ASIX) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference. ITEM 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 10.1 Credit Agreement, dated as of August 14, 2026, among AdvanSix Inc., the lenders from time to time party ther
AdvanSix Inc. reported Q2 2026 sequential earnings improvement, citing raw material costs shifting from a $10 million headwind in Q1 to a $39 million tailwind in Q2, and fully offsetting $72 million in YoY raw material headwinds via pricing. It noted lower plant nutrient volumes, near-record domestic granular ammonium sulfate volumes, and expects sequential EBITDA and cash flow improvement in H2 2026.
AdvanSix Inc. (ASIX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 News Release ADVANSIX ANNOUNCES SECOND QUARTER 2026 FINANCIAL RESULTS 2Q26 Sales of $421 million, up 3% versus prior year 2Q26 Earnings Per Share of $0.12; Adjusted Earnings Per Share of $0.19 2Q26 Cash Flow from Operations of $10 million Parsippany, N.J., August 7,
